Pfizer Inc.: Working together for a healthier world® At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products.
Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Baxter provides a broad portfolio of essential acute care and renal products, including sterile premixed IV solutions; large volume infusion pumps and needleless access devices; parenteral nutrition; anesthetics; and pharmacy automation, software and services; and home, acute and in-center dialysis.
Through our vision of the Autonomous Pharmacy, Omnicell is moving medication management forward to enable improved healthcare for everyone. Omnicell offers a powerful combination of advanced automation, data intelligence, and expert services to help improve patient safety, increase efficiency, lower costs, tighten regulatory compliance, and address population health challenges.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
AmerisourceBergen connects the creators of pharmaceutical products with the providers who care for patients. Our pharmaceutical sourcing, distribution and commercialization services deliver value and efficiency across healthcare. Powered by our 21,000 associates, we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500.
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products are used to help care for critically and chronically ill patients. We are driven to put lifesaving medicines and technologies in the hands of people who care for patients, and to find answers to the challenges they face.
Established in 1935, Cipla is a global pharmaceutical company with 46 manufacturing sites around the world and is among the most dispensed generic players in the U.S. Cipla produces 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to our 80+ markets.
Portola Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic diseases. The Company’s two FDA-approved medicines are Bevyxxa® (betrixaban), the first and only oral, once-daily Factor Xa inhibitor, and Andexxa® [coagulation facto
Arbor Pharmaceuticals, LLC is a specialty pharmaceutical company headquartered in Atlanta, GA. The portfolio of products marketed in the U.S. by Arbor includes Triptodur® (triptorelin) for extended release injectable suspension, and Cetylev® (acetylcysteine) Effervescent Tablets for Oral Solution with a lemon-mint flavor.
Astellas Pharma US, Inc., is a U.S. affiliate of Tokyo based Astellas Pharma Inc. Located in Northbrook, Illinois, the company serves as the headquarters for the Americas and employs nearly 3,000 people. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
CAPS®, the nation's largest network of outsourcing pharmacies, provides high-quality, ready-to-use, admixtures to hospitals and outpatient facilities nationwide. CAPS offers compounded sterile preparations from three 503B Outsourcing Facilities and dispenses patient-specific solutions from 22 regional pharmacies. CAPS is part of the B. Braun Group of Companies in the U.S.
Par Pharmaceutical develops, manufactures, and markets safe, innovative, and cost-effective generic pharmaceutical products. The Par portfolio includes sterile injectable products, distributed by Par Sterile Products. Par Pharmaceutical is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENL), a global specialty pharmaceutical company.
Paratek Pharmaceuticals is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are difficult to treat. At Paratek, we pursue solutions that enable positive outcomes and lead to positive patient stories.
As a national platform for compounded sterile preparations, QuVa Pharma is a leader in 503B outsourcing services. Run by a team with deep experience in cGMP and aseptic pharmaceutical manufacturing, QuVa takes end product testing to the highest level by testing EVERY batch, EVERY time – never releasing a product at-risk. EVERY batch undergoes USP sterility, USP endotoxin and HPLC potency.
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area.